| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Chennai Super Kings Cricket Limited |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | 1,060.20 | 1,132.42 | 839.08 | 460.66 | 390.57 |
| Total equity | 815.05 | 714.58 | 528.00 | 261.53 | 248.74 |
| Total liabilities | 245.14 | 417.84 | 311.08 | 199.13 | 141.83 |
| Non - Current liabilities | 12.92 | 7.49 | 4.56 | 4.75 | 0.45 |
| Current liabilities | 232.22 | 410.35 | 306.52 | 194.38 | 141.39 |
| ASSETS | 1,060.20 | 1,132.42 | 839.08 | 460.66 | 390.57 |
| Non-Current assets | 436.73 | 400.10 | 267.55 | 188.53 | 183.24 |
| Current assets | 623.46 | 732.33 | 571.53 | 272.12 | 207.33 |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| Net cash from/(used in) operating activities | -7.30 | 206.34 | 329.60 | 94.96 | 18.12 |
| Net cash from/(used in) investing activities | -228.21 | -74.61 | -180.81 | -195.09 | 1.13 |
| Net cash from/(used) in financing activities | -27.70 | 37.90 | -7.56 | -9.79 | -5.69 |
| Net increase /(decrease) in cash and cash equivalents | -263.21 | 169.63 | 141.23 | -109.93 | 13.55 |
| Cash and cash equivalents at the beginning of the year | 336.38 | 166.76 | 25.52 | 135.45 | 121.80 |
| Cash and cash equivalents at the end of the year | 70.74 | 336.38 | 166.76 | 25.52 | 135.35 |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| EBITDA Margin | 25.53% | 31.50% | 40.30% | 14.59% | 14.18% |
| EBIT Margin | 24.00% | 30.06% | 39.64% | 13.05% | 13.46% |
| Return on Equity (ROE) | 13.96% | 20.76% | 38.16% | 5.27% | 12.68% |
| Return on Capital Employed (ROCE) | 20.64% | 29.32% | 53.84% | 15.94% | 18.87% |
| Assets Turnover Ratio | 0.67 | 0.62 | 0.86 | 0.71 | 0.89 |
| Return on Assets | 10.73% | 13.10% | 24.01% | 2.99% | 8.08% |
| Net Profit Margin | 15.98% | 21.06% | 27.86% | 4.24% | 9.03% |
| Interest Coverage Ratio | 131.54 | 96.87 | 37.93 | 4.12 | 7.51 |
| Revenue Growth Rate (CAGR) | 1.09% | -2.63% | 122.34% | -6.83% | -2.07% |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| Revenue | 711.98 | 704.28 | 723.28 | 325.30 | 349.15 |
| Revenue from operations | 697.14 | 673.80 | 695.45 | 305.86 | 341.05 |
| Other income | 14.84 | 30.49 | 27.83 | 19.44 | 8.10 |
| Expenses | 542.40 | 494.77 | 444.12 | 293.16 | 308.40 |
| Finance cost | 1.30 | 2.19 | 7.56 | 10.30 | 6.26 |
| Employee benefit Expense | 25.19 | 16.63 | 6.68 | 3.80 | 3.19 |
| Depreciation and Amortisation expense | 10.87 | 10.16 | 4.74 | 5.03 | 2.51 |
| Other expenses | 14.93 | 464.04 | 424.97 | 274.03 | 296.44 |
| Profit/(loss) before tax | 169.58 | 209.51 | 279.16 | 32.14 | 40.75 |
| Tax Expense | 55.79 | 61.19 | 77.66 | 18.35 | 9.21 |
| Current tax | 55.05 | 61.03 | 77.24 | 18.64 | 11.02 |
| Deferred tax | 0.74 | 0.16 | 0.43 | -0.29 | -1.82 |
| Profit (Loss) for the period from continuing Operations | 113.79 | 148.32 | 201.49 | 13.79 | 31.54 |
| Particulars | 2025-26 | 2024-25 | 2023-24 | 2022-23 | 2021-22 |
|---|---|---|---|---|---|
| Revenue | 711.98 | 704.28 | 723.28 | 325.30 | 349.15 |
| Total Expense | 542.40 | 494.77 | 444.12 | 293.16 | 308.40 |
| Operating Expenses | 51.00 | 490.82 | 436.39 | 282.87 | 302.14 |
| Employee Expenses | 25.19 | 16.63 | 6.68 | 3.80 | 3.19 |
| Operating Income (EBIT) | 170.88 | 211.70 | 286.72 | 42.44 | 47.01 |
| Interest Expenses | 1.30 | 2.19 | 7.56 | 10.30 | 6.26 |
| Expenses from other activities | 14.93 | 464.04 | 424.97 | 274.03 | 296.44 |
| EBITDA | 181.75 | 221.85 | 291.46 | 47.47 | 49.52 |
| Net Worth | 815.05 | 714.58 | 528.00 | 261.53 | 248.74 |
| Taxes | 55.79 | 61.19 | 77.66 | 18.35 | 9.21 |
| Outstanding Shares | 379,425,004.00 | 379,425,004.00 | 379,425,004.00 | 308,153,074.00 | 308,153,074.00 |
| Earnings Per Share (EPS) | 3.00 | 3.91 | 5.31 | 0.45 | 1.02 |
| Total Assets | 1,060.20 | 1,132.42 | 839.08 | 460.66 | 390.57 |
| Total Liabilites | 245.14 | 417.84 | 311.08 | 199.13 | 141.83 |
| Total equity | 815.05 | 714.58 | 528.00 | 261.53 | 248.74 |
| Net cash from/(used in) operating activities | -7.30 | 206.34 | 329.60 | 94.96 | 18.12 |
| Net cash from/(used in) investing activities | -228.21 | -74.61 | -180.81 | -195.09 | 1.13 |
| Net cash from/(used) in financing activities | -27.70 | 37.90 | -7.56 | -9.79 | -5.69 |
